市场调查报告书
商品编码
1454021
到 2030 年生命征象监测系统市场预测:按产品类型、消费性穿戴装置、技术、应用、最终用户和地区进行的全球分析Vital Signs Monitoring Systems Market Forecasts to 2030 - Global Analysis By Product Type, Type, Consumer Wearables, Technology, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2023 年全球生命征象监测系统市场规模为 101 亿美元,预计在预测期内将以 10.5% 的复合年增长率成长,到 2030 年达到 204 亿美元。
生命征象监测系统是先进的医疗设备,旨在追踪重要的生理参数并及时检测健康异常。这些系统持续监测心率、血压、呼吸频率和体温等指标。利用尖端的感测器技术并提供即时资料,医疗保健专业人员可以快速回应患者病情的变化。这些系统可携式且用户友好,透过促进远端监控和早期疗育改善患者照护。
根据全球健康观察站的资料,2019年,71%的死亡是由于非传染性疾病(NCD)造成的。主要的非传染性疾病是心血管疾病(CVD),占所有非传染性疾病死亡的 45.0%;癌症,占所有非传染性疾病死亡的 22.0%;以及慢性阻塞性肺病(COPD),占所有非传染性疾病死亡的10.0%。
慢性病增加
随着高血压、糖尿病和心血管疾病等疾病变得越来越普遍,持续健康监测的需求也随之增加。生命体征监测系统透过提供关键参数的即时资料并支援慢性病的早期检测和管理发挥着至关重要的作用。该市场对用户友好的远端监控解决方案的需求激增,推动了创新。随着人们对预防性医疗保健的日益关注,市场正在不断扩大,以满足患者和医疗保健提供者不断增长的需求,从而促进了全面健康监测系统的动态发展。
初始成本和持续成本高
医疗保健组织可能会犹豫是否要投资此类系统,尤其是在资源有限的环境中。经济负担限制了普及并阻碍了提供者和患者的可及性。这一障碍减缓了先进监测技术融入主流医疗保健的速度,并抑制了持续远端患者监护的潜在优势。
家庭医疗保健需求不断增长
随着人们寻求更方便和个人化的医疗保健解决方案,对在家监测生命征象的偏好正在增加。生命征象监测系统透过提供使用者友善的行动装置来满足此需求,这些设备可实现持续的健康追踪。该市场正在见证可穿戴监控设备和远端医疗整合等创新的激增,促进远距患者照护。人口老化和 COVID-19 大流行等因素加速了向家庭医疗保健的转变,正在推动市场扩张,以满足患者对主动且易于使用的健康监测解决方案不断变化的需求。
越来越依赖数位平台进行资料存储
网路安全威胁是一个重大风险,可能使敏感的病患资讯面临风险。这导致医疗保健提供者和患者的抵制增加,阻碍了普及。对未授权存取和资料外洩的担忧可能会阻碍将先进监控技术引入医疗环境。因此,解决和缓解这些安全挑战对于建立对数位医疗解决方案的信任、确保患者资料的安全和合乎道德的使用以及促进可持续的市场成长至关重要。
COVID-19 的影响
随着人们对远端患者监护和远端医疗的日益关注,医疗保健提供者越来越多地利用这些系统来远端监测 COVID-19 患者。为了最大限度地减少病毒传播,对非接触式生命征象监测解决方案的需求正在迅速增加。此外,这场流行病凸显了早期发现和持续监测的重要性,刺激了对先进技术的投资。为了应对不断变化的医疗保健环境,市场正在见证技术创新和协作的兴起,在当前的全球健康危机期间,生命体征监测可以加强患者照护并支持医疗保健专业人员,该系统的作用得到了强调。
血压计细分市场预计将成为预测期内最大的细分市场
由于高血压和心血管疾病的盛行率不断上升,将推动对家庭血压监测设备的需求以及综合生命征象监测系统的同步成长,血压监测仪领域预计将出现良好的成长。将血压监测先进地整合到这些系统中增强了诊断能力并吸引了医疗保健专业人员和消费者。此外,随着技术的发展,技术创新和市场竞争的加剧提供了更准确和用户友好的解决方案。
预测期内,门诊血压计领域预估复合年增长率最高
预计动态血压计领域在预测期内将以最高复合年增长率成长。这是由于对连续和远端病患监测的需求,动态血压计在提供临床环境之外的即时资料方面发挥着至关重要的作用。与综合监测系统的整合扩大了市场范围,并允许进行更全面的健康评估。动态监视器有助于动态的市场格局,响应医疗保健专业人员和患者不断变化的偏好,寻求方便和持续的生命体征跟踪,最终推动更广泛的监护系统市场的创新和竞争。
预计亚太地区在预测期内将占据最大的市场占有率。其主要原因是老年人口不断增长、持续性疾病数量不断增加、人们对远端和无线设备的兴趣开拓以及保险覆盖政策的简化。这是由于该地区广泛的未满足需求,包括初级医疗保健,特别是在印度和中国等新兴市场。此外,在预测期内,该地区医疗旅游业的兴起和医疗保健行业的改善也为市场参与者提供了许多帮助。
由于人口众多、可支配收入高、患者对先进监测设备的认识不断提高,以及疟疾和伤寒等感染疾病率上升,北美将成为预测期内增长最快的地区,预计复合年增长率将很高。此外,老年人口的增加和家庭照护环境中对生命征象监测系统的需求不断增加,也促进了生命征象监测系统市场的成长。此外,该地区拥有良好的基本医疗设备报销制度,提高了医疗保健服务的认知度和可近性,从而带来了高需求。
According to Stratistics MRC, the Global Vital Signs Monitoring Systems Market is accounted for $10.1 billion in 2023 and is expected to reach $20.4 billion by 2030 growing at a CAGR of 10.5% during the forecast period. Vital Signs Monitoring Systems are advanced medical devices designed to track crucial physiological parameters, ensuring timely detection of health abnormalities. These systems continuously monitor indicators such as heart rate, blood pressure, respiratory rate, and body temperature. Utilizing cutting-edge sensor technology, they provide real-time data, enabling healthcare professionals to promptly respond to fluctuations in a patient's condition. Portable and user-friendly, these systems enhance patient care by facilitating remote monitoring and early intervention.
According to the Global Health Observatory data, in 2019, 71% of the deaths were due to Non-Communicable Diseases (NCDs). The major NCDs are Cardiovascular Diseases (CVDs), which caused 45.0% of all NCD deaths, cancer caused 22.0% of all NCD deaths, and Chronic Obstructive Pulmonary Disease (COPD) caused 10.0% of all NCD deaths, and diabetes caused 4.0% of all NCD deaths.
Increasing prevalence of chronic diseases
As conditions like hypertension, diabetes, and cardiovascular diseases become more prevalent, the demand for continuous health monitoring escalates. Vital Signs Monitoring Systems play a pivotal role by providing real-time data on crucial parameters, aiding in early detection and management of chronic conditions. The market experiences a surge in demand for user-friendly, remote monitoring solutions, fostering innovation in technology. With an increasing emphasis on preventive healthcare, the market expands to address the growing needs of patients and healthcare providers, contributing to the dynamic landscape of comprehensive health monitoring systems.
High initial costs and ongoing expenses
Healthcare institutions may hesitate to invest in these systems, especially in resource-limited environments. The financial burden limits widespread adoption, hindering accessibility for both providers and patients. This obstacle slows the integration of advanced monitoring technologies into mainstream healthcare practices, impeding the potential benefits of continuous, remote patient monitoring.
Growing demand for home-based healthcare
Individuals seek more convenient and personalized healthcare solutions, there is an increasing preference for monitoring vital signs at home. Vital Signs Monitoring Systems cater to this demand by offering user-friendly, portable devices that enable continuous health tracking. The market experiences a surge in innovations such as wearable monitoring devices and telehealth integrations, facilitating remote patient care. The shift towards home-based healthcare, accelerated by factors like aging populations and the COVID-19 pandemic, propels the market's expansion, meeting the evolving needs of patients for proactive and accessible health monitoring solutions.
Increasing reliance on digital platforms for data storage
Cybersecurity threats pose a significant risk, potentially compromising sensitive patient information. This raises reluctance among healthcare providers and patients, hindering widespread adoption. Fear of unauthorized access and data breaches may impede the integration of advanced monitoring technologies into mainstream healthcare practices. Thus, addressing and mitigating these security challenges are vital to building trust in digital healthcare solutions, ensuring the safe and ethical use of patient data, and fostering the sustained growth of the market.
Covid-19 Impact
With a heightened focus on remote patient monitoring and telehealth, healthcare providers increasingly utilize these systems to monitor COVID-19 patients remotely. The demand for non-contact vital signs monitoring solutions has surged to minimize virus transmission. Additionally, the pandemic has underscored the importance of early detection and continuous monitoring, driving investments in advanced technologies. The market has witnessed increased innovation and collaboration to meet the evolving healthcare landscape, emphasizing the role of Vital Signs Monitoring Systems in enhancing patient care and supporting healthcare professionals during the ongoing global health crisis.
The blood pressure monitors segment is expected to be the largest during the forecast period
The blood pressure monitors segment is estimated to have a lucrative growth, due to increasing prevalence of hypertension and cardiovascular diseases drives the demand for at-home blood pressure monitoring devices, fostering a parallel rise in comprehensive vital signs monitoring systems. Advanced integration of blood pressure monitoring into these systems enhances their diagnostic capabilities, attracting both healthcare professionals and consumers. Further the market experiences innovation and competitive expansion as technology evolves, offering more accurate and user-friendly solutions.
The ambulatory blood pressure monitors segment is expected to have the highest CAGR during the forecast period
The ambulatory blood pressure monitors segment is anticipated to witness the highest CAGR growth during the forecast period, owing to the demand for continuous and remote patient monitoring, ambulatory blood pressure monitors play a pivotal role in providing real-time data outside clinical settings. Their integration into comprehensive monitoring systems expands the market's scope, enabling a more holistic health assessment. Ambulatory monitors contribute to a dynamic market landscape, addressing the evolving preferences of healthcare professionals and patients for convenient and continuous vital signs tracking, ultimately fostering innovation and competitiveness within the broader monitoring systems market.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the growing geriatric population, rising occurrences of interminable disorders, and developing interest in remote and wireless devices combined with streamlined coverage policies are the main considerations credited to its share. This can be attributed to the extensive unmet needs in this region including primary healthcare, especially in developing markets, such as India and China. Moreover, the rising medical tourism and improving healthcare sectors in this region have a lot to offer the market players over the forecast period.
North America is projected to have the highest CAGR over the forecast period, owing to owing to its high population base, high disposable incomes, improvement in patient awareness about advanced monitoring devices, and increase in incidences of infectious diseases such as malaria and typhoid. Moreover, rise in geriatric population and increase in demand for vital signs monitoring devices for home care settings have contributed to the vital signs monitoring devices market growth. Thus the region also has high awareness and access to healthcare services with strong reimbursement coverage for essential medical devices, thereby leading to high demand.
Key players in the market
Some of the key players in the Vital Signs Monitoring Systems Market include CONTEC Medical Systems Co., Ltd., Criticare Systems, Inc., General Electric Company, Infinium Medical, Masimo Corporation, Medtronic plc, Mindray Medical International Limited, Natus Medical Incorporated, Nihon Kohden Corporation, Nonin Medical, Inc., Omron Healthcare, Philips Healthcare, Progetti srl, Rapid Response Monitoring, Schiller AG, Smiths Medical, Spacelabs Healthcare, SunTech Medical and Welch Allyn
In February 2024, Masimo and UCHealth Announce a Clinical Monitoring Partnership to Improve Care with Telehealth. The collaboration is designed to leverage the unique capabilities of both organizations and pursue their mutual goals of improving patient outcomes, reducing the cost of care, and transforming models of care delivery across the continuum
In January 2024, Medtronic Diabetes announces world's first approval for MiniMed(TM) 780G Systems with Simplera Sync(TM) disposable, all-in-one sensor. The MiniMed 780G system with Simplera Sync(TM) sensor will be available in Europe via limited release in spring 2024.
In January 2024, Mindray Unveils UX Series Endoscope Camera System, Empowering Surgical Precision with Innovative Technology. By integrating a new generation hardware platform with advanced software algorithms, the UX Series sets a new standard for image performance and potential for future expandability.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.